farnesol has been researched along with Arteriosclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernini, F; Corsini, A; Fumagalli, R; Paoletti, R; Raiteri, M; Soma, MR | 1 |
Afek, A; George, J; Goldberg, I; Haklai, R; Herz, I; Keren, G; Keren, P; Kloog, Y | 1 |
2 other study(ies) available for farnesol and Arteriosclerosis
Article | Year |
---|---|
Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Cell Division; Cell Movement; Cells, Cultured; Cholesterol Esters; Diterpenes; Farnesol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Macrophages, Peritoneal; Male; Mevalonic Acid; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Pravastatin; Rabbits; Rats; Rats, Sprague-Dawley; Simvastatin | 1995 |
Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice.
Topics: Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Autoantibodies; Cell Division; Cells, Cultured; Cholesterol; Dietary Fats; Disease Models, Animal; Enzyme Inhibitors; Farnesol; Injections, Intraperitoneal; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; ras Proteins; Salicylates; Spleen; Treatment Outcome; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2002 |